/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Such statements may address our plans, our strategies, our prospects, changes and trends in our business and the markets in which we operate under the heading Management s Discussion and Analysis of Financial Condition and Results of Operations ( MD&A ) or in other sections of this document. These and other risks and uncertainties are further discussed in other sections of this document.
$192.13
$4.62 (-2.35%)
EOD Sep 1, 2026
15.47% operating margin is respectable but not wide. ROIC at 11.57%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 14.2%, still solid.
At 34x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
34.4x earnings, 32.1x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$2.48B
▲ +14.2% YoY
Net Income (TTM)
$279M
▲ +21.7% YoY
Op. Margin
16.15%
ROIC
11.20%
▼ -1.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$303M
▼ -2.7% YoY
Op. Cash Flow (TTM)
$422M
▲ +16.6% YoY
Net Debt
$448M
Cash & Equiv.
$166M
5Y CAGR: +15.0%
5Y CAGR: +16.8%
Continue Research
SourceComputed from the 10-Q filed 31 Jul 2026, covering the period ending 27 Jun 2026, as reported to the SEC. Data last refreshed 3 Aug 2026. How this is calculated.
Price from market data, last close as of 1 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.
At a P/E of 34.4 and a price-to-free-cash-flow of 32.1, Spx Technologies (SPXC) trades above a two-stage DCF intrinsic value of about $191.98 per share, so at $192.13 the stock looks overvalued (0.1% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Spx Technologies scores 65/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $191.98 per share for SPXC, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $143.98. At today's $192.13, that puts the stock about 0.1% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Spx Technologies scores 65 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 16.2% operating margin and a 11.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. SPXC currently trades above its estimated intrinsic value and scores 65/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.